Optimized subcutaneous (SC) administration of BHV-1400 achieved rapid, deep, selective, and sustained lowering of Gd-IgA1, differentiating Biohaven's (BHVN) leading TRAP degrader for IgAN from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback